Concepedia

J. Moore

JM

21

Publications

3.2K

Citations

17

H-Index

1985

Active since

Affiliations

Royal Marsden Hospital(Current)

Royal Marsden NHS Foundation Trust

University Hospitals Birmingham NHS Foundation Trust

St Thomas' Hospital

The University of Texas MD Anderson Cancer Center

J. Moore is an author at Royal Marsden Hospital specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

1985–2023

21

Publications

21

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

Hyperthermic Oncology 1984

Helen R. Griffiths, J. Moore · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · 1985 · 526 citations

, , +4

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn et al. · PubMed · 1999 · 300 citations

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Z Arlin, Delvyn C. Case, J. Moore et al. · PubMed · 1990 · 199 citations

A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily

Philip Savage, Vicki L. Horton, J. Moore et al. · British Journal of Cancer · 1996 · 107 citations · Full text

, , +2

Rows per page

1–5 of 21